Cardiomyopathy

Clinical Trial Finder

Many patients with cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)

Conditions:   Duchenne Muscular Dystrophy;   Cardiomyopathy
Intervention:   Drug: Allogeneic Cardiosphere-Derived Cells (CAP-1002)
Sponsor:   Capricor Inc.
Not yet recruiting - verified June 2015

Group Medical Visits in Heart Failure

Condition:   Heart Failure
Intervention:   Behavioral: Group medical visits
Sponsor:   Department of Veterans Affairs
Recruiting - verified June 2015

Cardiac MRI in Pulmonary Hypertension

Condition:   Pulmonary Hypertension
Intervention:   Device: Magnetic resonance Imaging
Sponsor:   University of California, San Francisco
Not yet recruiting - verified June 2015

A Trial of Autologous Bone Marrow Derived Stem Cells in Paediatric Heart Failure

Condition:   Dilated Cardiomyopathy
Intervention:   Biological: stem cell injection
Sponsor:   Great Ormond Street Hospital for Children NHS Foundation Trust
Completed - verified June 2015

A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis

Condition:   TTR-mediated Amyloidosis
Intervention:   Drug: Revusiran (ALN-TTRSC)
Sponsor:   Alnylam Pharmaceuticals
Active, not recruiting - verified June 2015

Right Ventricle (RV) Markers of Future Pacing Induced Ventricular Dysfunction - Pilot

Condition:   Sick Sinus Syndrome
Intervention:  
Sponsors:   Basildon and Thurrock University Hospitals NHS Foundation Trust;   Anglia Ruskin University
Recruiting - verified June 2015

Thoratec Corporation HeartMate III™ CE Mark Clinical Investigation Plan

Condition:   Advanced Refractory Left Ventricular Heart Failure
Intervention:   Device: Left Ventricular Assist System (LVAS)
Sponsors:   Thoratec Corporation;   Center for Life Sciences (C3TK);   Emergo Group;   Krakow Cardiovascular Research Institute
Active, not recruiting - verified June 2015

Utilising Lifemap to Investigate Malignant Arrhythmia Therapy

Conditions:   Ischemic Cardiomyopathy;   Sudden Cardiac Death;   Implantable Defibrillator User;   Myocardial Infarction;   Arrhythmias, Cardiac
Intervention:  
Sponsors:   University Hospitals, Leicester;   University of Leicester
Recruiting - verified June 2015

Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)

Condition:   Chronic Myocardial Ischemia
Intervention:   Other: Autologous bone marrow derived-CD133+ cells
Sponsors:   Centro Cardiologico Monzino;   Azienda Ospedaliera Città della Salute e della Scienza di Torino;   Azienda Ospedaliera San Gerardo di Monza
Recruiting - verified June 2015

Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Dilated Cardiomyopathy and Heart Failure.

Condition:   Idiopathic Dilated Cardiomyopathy
Interventions:   Drug: Infusion of autologous mononuclear bone marrow cells;   Drug: Placebo infusion
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas 
Recruiting - verified June 2015

Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Insufficiency.

Condition:   Hypertrophic Obstructive Cardiomyopathy
Interventions:   Procedure: myoectomy;   Procedure: Mitral valve surgery;   Procedure: Mitral valve surgery
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Completed - verified July 2015

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Condition:   Transthyretin (TTR) Amyloid Cardiomyopathy
Interventions:   Drug: Tafamidis;   Drug: Tafamidis;   Drug: Placebo
Sponsor:   Pfizer
Recruiting - verified June 2015

Polypharmacy in the Heart Failure Patient: Are All Prescribed Drug Classes Required? Statin Withdrawal Study

Condition:   Heart Failure
Interventions:   Drug: Withdrawal of statin therapy;   Drug: Statin therapy
Sponsor:   The Alfred
Completed - verified June 2015

Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study

Condition:   Heart Failure
Interventions:   Drug: Aspirin;   Other: withdrawal of aspirin
Sponsor:   The Alfred
Completed - verified June 2015

A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure

Conditions:   Heart Failure;   Dilated Cardiomyopathy
Interventions:   Device: Algisyl-LVR;   Drug: Standard medical therapy
Sponsor:   LoneStar Heart, Inc.
Active, not recruiting - verified June 2015

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)

Conditions:   Transthyretin Mutations;   Transthyretin Amyloidosis
Intervention:   Other: None. Observational Study.
Sponsor:   Pfizer
Recruiting - verified June 2015

Get CardioSmart

You're Invited